Business

UC Asset Wins SEC Qualification for $5M Cannabis Property Offering

mm
Published
Add MyCannabis.com to your preferred sources on Google

UC Asset LP can start selling preferred shares to the public after the Securities and Exchange Commission qualified its offering circular for a secondary public offering, the Atlanta-based cannabis real estate investor announced on August 25, 2026. The qualification clears the company to issue up to $5 million in preferred shares carrying an 8% annual dividend, with the majority of proceeds earmarked for acquiring additional cannabis properties.

The SEC entered its notice of qualification on August 24, 2026, ending a review that ran more than fifteen months. UC Asset filed the initial offering statement in May 2025 under Regulation A, the federal exemption that lets smaller companies raise money from the general public without a full stock-exchange registration, and amended it repeatedly through August 17, 2026. The shares will be offered under what the company calls a secondary public offering: a public sale of units in a partnership that already trades over the counter, aimed at retail investors rather than institutions.

The economics of the offer are spelled out in unusually direct terms for a cannabis-linked raise. Preferred shareholders are entitled to an 8% annual preferred dividend, a rate the company contrasts with the roughly 4.9% total return that equity REITs posted in 2024, per Nareit data. Founder Larry Wu framed the raise as a bet that cannabis property values have bottomed.

“According to our research, the cannabis industry has hit rock bottom in recent years,” Wu said in the company’s announcement. “Property prices have likely reached a historic low. Meanwhile, major policy trends favor the industry, including the federal government’s ongoing process to move cannabis from Schedule I to Schedule III under the Controlled Substances Act. We believe a new wave of rapid growth for the cannabis industry is imminent.”

On coverage for the dividend, Wu pointed to the existing portfolio: “The adjusted annualized yields on our current cannabis property portfolio for the past three years, including the first six months of 2026, were 14.4%, 13.2%, and 13.5%, respectively. If the net proceeds from our offering can be invested in similar properties, those investments will generate sufficient profit to cover the distribution of an 8% dividend.”

The Filing Trail Behind the Qualification

The offering’s path through the SEC was slow even by Regulation A standards. UC Asset filed its Form 1-A offering statement on May 8, 2025, and returned with amendments in June, July and August of that year, then again in June, July and August of 2026. While the review dragged on, the company kept the plan alive with a $250,000 bridge loan from three existing shareholders, announced July 24, 2026, to cover marketing and sales costs for the offering. That loan was contingent on qualification: the commitment would have been canceled automatically had the SEC not qualified the filing within three months. It carries no interest, matures in 12 months, and gives the lending shareholders the right to redeem shares at 100% of their original purchase price up to the loan amount, or at 75% of purchase price up to 150% of the loan amount.

The instrument being sold is the company’s Series C preferred units, an 8% accumulative and convertible class designated in June 2026, per the offering’s SEC exhibits. UC Asset describes itself as one of only four publicly traded U.S. companies dedicated to cannabis property investment, structured as a master limited partnership that buys cultivation real estate outfitted for medical cannabis production.

By the Numbers

  • Maximum offering size: $5 million in preferred shares
  • Preferred dividend: 8% annually
  • Adjusted annualized yields on UC Asset’s cannabis property portfolio: 14.4%, 13.2% and 13.5% across the past three years, including the first half of 2026
  • Equity REIT total return in 2024: approximately 4.9%, per Nareit
  • Bridge loan for offering marketing: $250,000, interest-free, 12-month maturity
  • SEC review timeline: initial filing May 8, 2025; final amendment August 17, 2026; qualification notice August 24, 2026

What Comes Next for the Offering

Qualification is permission, not completion: UC Asset still has to sell the shares. The company says it is working with potential broker partners to formulate a distribution plan for the offering, and no underwriter or selling-agent agreement has been announced. Wu attached his own caveat to the yield math, noting that the performance of the existing portfolio does not guarantee similar performance from future investments. With the circular qualified, the bridge loan from the three shareholder-lenders is now unlocked to fund the marketing push the company has been staging since July 2026.

mm

Marcus Lin is an AI-generated analyst at MyCannabis.com, covering cannabis companies, industry strategy, and market structure across regulated jurisdictions. His work focuses on how licensed producers, processors, and ancillary businesses operate within evolving regulatory environments—and how business decisions shape long-term market viability.

With a business-focused and analytical perspective, Marcus examines company strategy, consolidation trends, supply chain dynamics, and capital deployment across the cannabis sector. He places particular emphasis on execution, regulatory alignment, and the structural factors that determine whether companies can scale sustainably in legal markets.

Articles authored by Marcus Lin are AI-generated and reviewed by MyCannabis.com’s editorial team to ensure accuracy, context, and responsible coverage of cannabis industry developments in regulated markets.